Volume 69 Received 12 December 2012 | ||||||||||
| ||||||||||
aLaboratoire de Chimie Organique Appliquée, Université Sidi Mohamed, Ben Abdallah, Faculté des Sciences et Techniques, Route d'immouzzer, BP 2202 Fès, Morocco,bLaboratoire de Chimie Organique Hétérocyclique URAC21, Faculté des Sciences, Université Mohammed V-Agdal, Avenue Ibn Battouta, BP 1014, Rabat, Morocco,cInstitute of Nanmaterials and Nanotechnology, MASCIR, Rabat, Morocco, and dLaboratoire de Chimie du Solide Appliquée, Faculté des Sciences, Université Mohammed V-Agdal, Avenue Ibn Battouta, BP 1014, Rabat, Morocco
Correspondence e-mail: d_belaziz@yahoo.fr
In the title compound, C15H14N2O, the fused five- and six-membered ring system is essentially planar, the maximum deviation from the mean plane being 0.009 (1) Å. The benzimidazol-2(3H)-one residue is nearly perpendicular to the benzyl ring, forming a dihedral angle of 77.41 (6)°. In the crystal, inversion dimers are formed by pairs of N-H
O hydrogen bonds; these dimers are linked by weak C-H
O interactions into a two-dimensional array in the (102) plane.
For pharmacological and biochemical properties of benzimidazole derivatives, see: Lee et al. (2004
); Deligeorgiev et al. (2011
); Scott et al. (2002
); Gothelf et al. (1998
). For related structures, see: Belaziz et al. (2012
); Ouzidan et al. (2011
).
|
|
|
| |||||||||||||||||||||||||||
Data collection: APEX2 (Bruker, 2009
); cell refinement: SAINT (Bruker, 2009
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012
); software used to prepare material for publication: PLATON (Spek, 2009
) and publCIF (Westrip,2010
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: TK5182 ).
The authors thank the Unit of Support for Technical and Scientific Research (UATRS, CNRST) for the X-ray measurements.
Belaziz, D., Kandri Rodi, Y., Ouazzani Chahdi, F., Essassi, E. M., Saadi, M. & El Ammari, L. (2012). Acta Cryst. E68, o3212.
![[details]](../../../../../../e/graphics/details.gif)
Bruker (2009). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Deligeorgiev, T., Kaloyanova, S. & Vasilev, S. (2011). Dyes Pigm. 90, 170-1276.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Gothelf, K. V. & Jørgensen, K. A. (1998). Chem. Rev. 98, 863-909.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Lee, Y. H. & Pavlostathis, S. G. (2004). Water Res. 38, 1838-1852.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Ouzidan, Y., Essassi, E. M., Luis, S. V., Bolte, M. & El Ammari, L. (2011). Acta Cryst. E67, o1822.
![[details]](../../../../../../e/graphics/details.gif)
Scott, L. J., Dunn, C. J., Mallarkey, G. & Sharpe, M. (2002). Drugs, 62, 1503-1538.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.
![[details]](../../../../../../j/graphics/details.gif)